Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
$86.28
Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
31 Oct 2025, 11:49
Chart & Data from IG
DraftKings (NASDAQ: DKNG) closed the last trading session at $43.44 per share, extending its weekly winning streak to seven consecutive weeks. This sustained rally indicates strong bullish momentum, but technical indicators suggest a potential near-term pullback as earnings approach.
With quarterly earnings set for tomorrow, investors are watching whether DraftKings can break above key resistance or face a potential pullback:
Resistance: $44.55 (upper trendline of the wedge). A break above this level could trigger a rally toward $49.55 as buyers step in.
Support: $39 (lower trendline support). A break below this level could lead to further declines toward $35.97, and possibly $35.11 if selling pressure intensifies.
With DraftKings stock recovering from last year’s April-July pullback, it now sits at a pivotal point heading into Q1 2025. The upcoming earnings report could be the catalyst for a breakout or a reversal, making these key price levels critical for traders and investors.
Will DraftKings continue its seven-week rally or see a post-earnings correction? Keep an eye on $44.55 resistance and $39 support for market direction.